Company intelligence / Profile preview

Proteome Sciences

Ownership: Private
Employees: ~31
Development stage: Commercial

Overview

Proteome Sciences is a leading CRO specializing in applied proteomics. It offers high-sensitivity proprietary technologies for protein biomarker discovery, quantification, and assay development. Its platforms are widely used by biopharma clients globally to support drug development pipelines from research through clinical trials. The company's reagents are distributed worldwide via Thermo Fisher Scientific.

Modalities: ProteinPeptides
Industry: Contract Research Organization

Partnerships

Thermo Fisher Scientific (distribution partner for TMT reagents)

Beyond the preview

Go deeper on Proteome Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Proteome Sciences.

Explore the full profile